Clinical Trial: A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07002905) titled 'A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities' on May 15.

Brief Summary: This randomized, double-blind, placebo-controlled phase IIa study is designed to evaluate the efficacy, safety, and tolerability of ASC30 Tablets and ASC30 Tablets A1.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Chronic Weight Management

Intervention: DRUG: ASC30 tablets or ASC30 tablets A1 or placebo

Drug: ASC30 tablets or ASC30 tablets A1 administered orally daily Drug: Placebo administered orally daily

Recruitment Status: RECRUITING

Sponso...